Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China
· Delayed Price · Currency is CNY 30.34
-0.25 (-0.82%)
At close: Jul 4, 2025, 2:57 PM CST
SHE:301166 Revenue
Shanghai Universal Biotech had revenue of 216.37M CNY in the quarter ending March 31, 2025, a decrease of -20.34%. This brings the company's revenue in the last twelve months to 1.06B, down -13.15% year-over-year. In the year 2024, Shanghai Universal Biotech had annual revenue of 1.12B, down -8.82%.
Revenue (ttm)
1.06B
Revenue Growth
-13.15%
P/S Ratio
2.45
Revenue / Employee
1.62M
Employees
655
Market Cap
2.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.12B | -108.07M | -8.82% |
| Dec 31, 2023 | 1.23B | 30.70M | 2.57% |
| Jan 1, 2023 | 1.20B | 85.46M | 7.70% |
| Jan 1, 2022 | 1.11B | 260.59M | 30.69% |
| Dec 31, 2020 | 849.08M | 62.15M | 7.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |